Capital Stack
The Capital Stack for AI × Drug Discovery
59firms with verified AI-biotech investment activity — dedicated venture funds, pharma corporate venture arms, strategic AI infrastructure investors, seed specialists, and European funds. Every entry cross-referenced against the firm's public portfolio before inclusion.
59
Firms tracked
124
Portfolio companies
178
Verified investments
Venture Capital
27 firms · Dedicated AI × biotech fundsa16z Bio + HealthUSA6▪Ampersand Capital PartnersUSA2▪ARCH Venture PartnersUSA6▪Atlas VentureUSA4▪BioGeneration VenturesNetherlands3▪Catalio Capital ManagementUSA3▪Civilization VenturesUSA2▪DCVC BioUSA5▪Flagship PioneeringUSA9▪Foresite CapitalUSA4▪GV (Google Ventures)USA5▪Hoxton VenturesUK2▪Khosla VenturesUSA4▪Lux CapitalUSA5▪MedicxiUK3▪Mubadala CapitalUAE1▪NFXUSA3▪Obvious VenturesUSA2▪OrbiMedUSA4▪Perceptive AdvisorsUSA3▪Polaris PartnersUSA3▪RA Capital ManagementUSA4▪Section 32USA3▪Sofinnova PartnersFrance4▪Temasek HoldingsSingapore4▪Third Rock VenturesUSA4▪Versant VenturesUSA4▪
Corporate Venture
15 firms · Pharma strategic investment armsAmgen VenturesUSA2▪AstraZeneca R&A Ventures (via Alexion)USA2▪Boehringer Ingelheim Venture FundGermany2▪Bristol Myers Squibb VenturesUSA1▪Eli Lilly VenturesUSA2▪GSK NurtureUK1▪Johnson & Johnson Innovation - JJDCUSA4▪Leaps by BayerGermany4▪MSD Global Health Innovation FundUSA3▪Novartis BiomeSwitzerland1▪Novartis Venture FundSwitzerland4▪Pfizer VenturesUSA4▪Roche Venture FundSwitzerland4▪Sanofi VenturesUSA3▪Takeda VenturesUSA2▪